<code id='63957EF0A9'></code><style id='63957EF0A9'></style>
    • <acronym id='63957EF0A9'></acronym>
      <center id='63957EF0A9'><center id='63957EF0A9'><tfoot id='63957EF0A9'></tfoot></center><abbr id='63957EF0A9'><dir id='63957EF0A9'><tfoot id='63957EF0A9'></tfoot><noframes id='63957EF0A9'>

    • <optgroup id='63957EF0A9'><strike id='63957EF0A9'><sup id='63957EF0A9'></sup></strike><code id='63957EF0A9'></code></optgroup>
        1. <b id='63957EF0A9'><label id='63957EF0A9'><select id='63957EF0A9'><dt id='63957EF0A9'><span id='63957EF0A9'></span></dt></select></label></b><u id='63957EF0A9'></u>
          <i id='63957EF0A9'><strike id='63957EF0A9'><tt id='63957EF0A9'><pre id='63957EF0A9'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:246
          HHS 2020
          PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

          WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

          The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

          advertisement

          PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          ActiGraph execs on goal of drug approvals with digital endpoints
          ActiGraph execs on goal of drug approvals with digital endpoints

          JeremeyWyattActiGraphAsdrugmakerswadeintousingdigitalhealthtechnologies,ActiGraphhasmadeitsmissionto

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Health care needs a new profession: neuroimaging counseling

          AnMRIscanimageofabrainALAINJOCARD/AFPviaGettyImagesUntilrecently,gettinganMRImeanttravelingtothehosp